Bitter Melon Extracts Enhance the Activity of Chemotherapeutic Agents Through the Modulation of Multiple Drug Resistance

Abstract

Recently we demonstrated that extracts of bitter melon (BME) can be used as a preventive/therapeutic agent in colon cancers. Here, we determined BME effects on anticancer activity and bioavailability of doxorubicin (DOX) in colon cancer cells. BME enhanced the effect of DOX on cell proliferation and sensitized the cells towards DOX upon pretreatment. Furthermore, there was both increased drug uptake and reduced drug efflux. We also observed a reduction in the expression of Multidrug resistance conferring proteins (MDRCP) P-glycoprotein, MRP-2 and BCRP. Further BME suppressed DOX efflux in MDCK cells overexpressing the three efflux proteins individually, suggesting that BME is a potent inhibitor of MDR function. Next, we determined the effect of BME on PXR, a xenobiotic sensing nuclear receptor and a transcription factor that controls the expression of the three MDR genes. BME suppressed PXR promoter activity thereby suppressing its expression. Finally, we determined the effect of AMPK pathway on drug efflux because we have previously demonstrated that BME affects the pathway. However, inhibiting AMPK did not affect drug resistance, suggesting that BME may use different pathways for the anticancer and MDR modulating activities. Together, these results suggest that BME can enhance the bioavailability and efficacy of conventional chemotherapy.

Natural Product Modulators to Overcome Multidrug Resistance In Cancer

“…BME was shown to suppress PXR expression, a xenobiotic sensing nuclear receptor and a transcription factor that controls the expression of the three MDR genes promoter activity (102).…”

EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells

“…Colorectal cancer (CRC) is the second most prevalent cancer and the third leading cause of cancer deaths worldwide (1). Globally more than 1 million new cases were reported annually resulting in about 500,000 deaths worldwide per year (2).…”

Radiation‐Sensitive Dendrimer‐Based Drug Delivery System

“…Radiation affects cells directly by damaging DNA and indirectly by exciting water molecules and producing free radicals. Exposure to γ‐radiation mediates the lysis of water, generating reactive oxygen species (ROS) and causing functional deficiency and apoptosis of cells 2, 3, 4. In certain tumors, cancer cell survival rates after radiotherapy are high (e.g., early‐stage laryngeal cancer and nonsmall cell lung cancer) 5.…”

“…High‐energy ionizing γ‐radiation penetrates deep in suspect tumor tissue targeting cancer cells 4. Tissue penetration of γ‐radiation allows it to be used as an external stimulus, triggering localized release of drugs 33.…”